+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shrimp Disease Diagnostics Market by Technology, Diagnostic Method, Application, End User, Disease Type - Global Forecast 2025-2030- Product Image
Shrimp Disease Diagnostics Market by Technology, Diagnostic Method, Application, End User, Disease Type - Global Forecast 2025-2030- Product Image
Sale

Shrimp Disease Diagnostics Market by Technology, Diagnostic Method, Application, End User, Disease Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5017278
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The shrimp disease diagnostics market is advancing rapidly as aquaculture operators face growing disease risks and increasingly complex supply chain dynamics. New technologies and evolving regulatory requirements are changing how shrimp farmers, laboratories, and industry stakeholders tackle pathogen detection and stock protection.

Market Snapshot: Shrimp Disease Diagnostics Market Growth

The shrimp disease diagnostics market grew from USD 478.10 million in 2024 to USD 517.54 million in 2025. It is projected to maintain strong momentum, with a compound annual growth rate (CAGR) of 7.94%, reaching USD 756.45 million by 2030. This expansion reflects increasing disease challenges, the adoption of molecular and immunological diagnostics, and higher biosecurity standards across major global aquaculture regions.

Scope & Segmentation

This report delivers a structured breakdown of the shrimp disease diagnostics market, providing deep analysis across technology, diagnostic methods, applications, user groups, disease types, and regions.

  • Technology: Enzyme Linked Immunosorbent Assay, Loop Mediated Isothermal Amplification, Next Generation Sequencing, Polymerase Chain Reaction (including Multiplex PCR, Quantitative PCR, and Reverse Transcription PCR)
  • Diagnostic Method: Histopathological Diagnostics, Immunological Diagnostics (such as Enzyme Linked Immunosorbent Assay, Lateral Flow Immunoassay, Western Blot), Microbiological Diagnostics, Molecular Diagnostics
  • Application: Monitoring, Outbreak Investigation, Research, Screening
  • End User: Academic Institutions, Aquaculture Farms, Diagnostic Laboratories, Research Institutes
  • Disease Type: Bacterial Diseases, Fungal Diseases, Parasitic Diseases, Viral Diseases
  • Region: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, France, Russia, Saudi Arabia, South Africa), Asia-Pacific (such as China, India, Japan, Australia, Indonesia, Thailand, Vietnam)
  • Key Companies: Thermo Fisher Scientific, Danaher Corporation, F. Hoffmann-La Roche, Abbott Laboratories, PerkinElmer, QIAGEN, Bio-Rad Laboratories, Zoetis, Merck & Co., Ceva Santé Animale, among others

Key Takeaways for Senior Decision-Makers

  • The drive toward early disease detection is leading to widespread adoption of field-deployable assays and the integration of rapid immunoassays directly on shrimp farms.
  • Collaborative partnerships between research institutions, technology providers, and industry operators accelerate the validation and market introduction of new diagnostic platforms.
  • Advances in multiplex and high-throughput sequencing bring enhanced pathogen identification capabilities while improving laboratory efficiency and supporting scalable disease surveillance.
  • Blockchain-driven traceability solutions are emerging, linking diagnostic data to supply chain tracking and biosecurity management for improved transparency and risk mitigation.
  • Customized diagnostics tailored to regional pathogen profiles are supporting both large-scale and smallholder operations, promoting flexibility and resilience in disease management strategies.

Impact of United States Tariff Measures

In 2025, new tariff policies in the U.S. have influenced reagent costs and altered global sourcing strategies for shrimp disease diagnostics. These measures prompted many laboratories to explore alternative suppliers and invest in local reagent production to control expenses. Industry participants are also leveraging regional trade agreements to maintain steady access to testing materials, while balancing compliance costs in export-focused operations.

Shrimp Disease Diagnostics Market Methodology & Data Sources

This analysis is grounded in a mixed-methods approach, combining interviews with diagnostic executives, shrimp farm operators, and technology providers, with extensive reviews of peer-reviewed publications and regulatory documents. Quantitative insights are based on triangulation with shipment and trade data, complemented by competitive benchmarking of leading market players to support reliable and actionable conclusions.

Why This Report Matters

  • Enables strategic decision-making by providing targeted insights into technology direction, regional developments, and evolving best practices in shrimp disease diagnostics.
  • Supports investment and operational planning by highlighting regulatory, tariff, and supply chain impacts critical to market sustainability.
  • Guides R&D and partnership strategies by detailing competitor innovations and validation cycles across industry segments.

Conclusion

The shrimp disease diagnostics market is at a pivotal stage, where technological innovation and global collaboration are redefining disease management. Strategic choices rooted in robust diagnostics and agile supply networks will define future success for industry leaders and emerging players alike.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of CRISPR-based point-of-care diagnostic assays for shrimp pathogens enabling faster detection
5.2. Integration of AI-powered predictive analytics with shrimp farm telemetry for early disease outbreak alerts
5.3. Development of multiplex PCR assays for simultaneous detection of multiple shrimp viral and bacterial diseases
5.4. Growing use of portable isothermal amplification devices for on-site shrimp disease monitoring at farms
5.5. Implementation of next generation sequencing platforms for comprehensive shrimp pathogen surveillance programs
5.6. Emergence of handheld biosensor chips leveraging nanotechnology for rapid shrimp pathogen identification
5.7. Expansion of IoT-connected water quality sensors coupled with disease diagnostic tools to optimize shrimp health management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Shrimp Disease Diagnostics Market, by Technology
8.1. Introduction
8.2. Enzyme Linked Immunosorbent Assay
8.3. Loop Mediated Isothermal Amplification
8.4. Next Generation Sequencing
8.5. Polymerase Chain Reaction
8.5.1. Multiplex PCR
8.5.2. Quantitative PCR
8.5.3. Reverse Transcription PCR
9. Shrimp Disease Diagnostics Market, by Diagnostic Method
9.1. Introduction
9.2. Histopathological Diagnostics
9.3. Immunological Diagnostics
9.3.1. Enzyme Linked Immunosorbent Assay
9.3.2. Lateral Flow Immunoassay
9.3.3. Western Blot
9.4. Microbiological Diagnostics
9.5. Molecular Diagnostics
10. Shrimp Disease Diagnostics Market, by Application
10.1. Introduction
10.2. Monitoring
10.3. Outbreak Investigation
10.4. Research
10.5. Screening
11. Shrimp Disease Diagnostics Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Aquaculture Farms
11.4. Diagnostic Laboratories
11.5. Research Institutes
12. Shrimp Disease Diagnostics Market, by Disease Type
12.1. Introduction
12.2. Bacterial Diseases
12.3. Fungal Diseases
12.4. Parasitic Diseases
12.5. Viral Diseases
13. Americas Shrimp Disease Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Mexico
13.4. Argentina
13.5. Brazil
13.6. Canada
14. Europe, Middle East & Africa Shrimp Disease Diagnostics Market
14.1. Introduction
14.2. Egypt
14.3. Nigeria
14.4. Qatar
14.5. Poland
14.6. Israel
14.7. Italy
14.8. Finland
14.9. Netherlands
14.10. Switzerland
14.11. United Arab Emirates
14.12. Saudi Arabia
14.13. Sweden
14.14. Germany
14.15. Spain
14.16. Russia
14.17. Norway
14.18. France
14.19. Turkey
14.20. Denmark
14.21. United Kingdom
14.22. South Africa
15. Asia-Pacific Shrimp Disease Diagnostics Market
15.1. Introduction
15.2. Malaysia
15.3. South Korea
15.4. Australia
15.5. Thailand
15.6. Vietnam
15.7. Singapore
15.8. Taiwan
15.9. Philippines
15.10. India
15.11. China
15.12. Japan
15.13. Indonesia
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific, Inc.
16.3.2. Danaher Corporation
16.3.3. F. Hoffmann-La Roche Ltd
16.3.4. Abbott Laboratories
16.3.5. PerkinElmer, Inc.
16.3.6. QIAGEN N.V.
16.3.7. Bio-Rad Laboratories, Inc.
16.3.8. Zoetis Inc.
16.3.9. Merck & Co., Inc.
16.3.10. Ceva Santé Animale S.A.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SHRIMP DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. SHRIMP DISEASE DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. SHRIMP DISEASE DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. SHRIMP DISEASE DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. SHRIMP DISEASE DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SHRIMP DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY OUTBREAK INVESTIGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY OUTBREAK INVESTIGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 108. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 109. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 112. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 113. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 114. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 115. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 150. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 151. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 152. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 153. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 154. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 155. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 156. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 157. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 162. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 182. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 183. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 184. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 185. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 186. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 187. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 192. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 193. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 196. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 197. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 198. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 199. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 200. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 201. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 206. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 207. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 210. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 211. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 212. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 213. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 214. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 215. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 220. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 221. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 224. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 225. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 226. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 227. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 228. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 229. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 234. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 235. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 238. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 243. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 248. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 249. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 252. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 253. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 254. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 255. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 256. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 257. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 262. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 263. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 266. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 267. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 268. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 269. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 270. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 271. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 276. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 283. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 284. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 285. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 290. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 291. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 294. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 295. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2024 (USD MILLION)
TABLE 296. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025-2030 (USD MILLION)
TABLE 297. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 298. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 299. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 304. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYME

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Ceva Santé Animale S.A.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 517.54 Million
Forecasted Market Value ( USD ) by 2030 $ 756.45 Million
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Shrimp Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Shrimp Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 239 Pages
  • Global
From
Animal Virus Detection Kit Market by Technology (Cripr Based, Enzyme Linked Immunosorbent Assay, Loop Mediated Isothermal Amplification), Animal Type (Aquaculture, Companion Animals, Livestock), End User, Sample Type, Distribution Channel, Virus Type - Global Forecast 2025-2030 - Product Image

Animal Virus Detection Kit Market by Technology (Cripr Based, Enzyme Linked Immunosorbent Assay, Loop Mediated Isothermal Amplification), Animal Type (Aquaculture, Companion Animals, Livestock), End User, Sample Type, Distribution Channel, Virus Type - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Veterinary Drug Market by Product Category (Anti-Infectives, Anti-Inflammatories, Parasiticides), Route Of Administration (Inhalation, Injectable, Oral), Animal Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Veterinary Drug Market by Product Category (Anti-Infectives, Anti-Inflammatories, Parasiticides), Route Of Administration (Inhalation, Injectable, Oral), Animal Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Veterinary Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report by Animal (Companion, Livestock), Technology (Immunodiagnostics, Molecular Diagnostics), Product, Infection, End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Veterinary Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report by Animal (Companion, Livestock), Technology (Immunodiagnostics, Molecular Diagnostics), Product, Infection, End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2025-2033 - Product Image

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From

About the Shrimp Disease Diagnostics Market

The Shrimp Disease Diagnostics market is a segment of the Animal Healthcare/Veterinary industry. It focuses on the diagnosis and treatment of diseases that affect shrimp, a type of crustacean. Diagnostic tests are used to identify the presence of disease-causing agents, such as bacteria, viruses, and parasites. These tests can be used to detect the presence of disease in shrimp, as well as to monitor the effectiveness of treatments. Diagnostic tests are also used to monitor the health of shrimp populations, as well as to detect the presence of disease-causing agents in the environment. The Shrimp Disease Diagnostics market is driven by the increasing demand for shrimp, as well as the need to ensure the health and safety of shrimp populations. The market is also driven by advances in technology, such as the development of new diagnostic tests and the use of molecular techniques. Companies in the Shrimp Disease Diagnostics market include Bio-Rad Laboratories, Thermo Fisher Scientific, QIAGEN, and Genetwister Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.